BioNTech SE ADR (BNTX)

BioNTech Envisions Revolutionary Cancer Treatments - TipRanks.com - TipRanks

TipRanks

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

MarketWatch

Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe - The Globe and Mail

The Globe and Mail

Aktionärinnen und Aktionäre stimmen auf der ordentlichen Hauptversammlung 2024 der BioNTech SE allen Tagesordnungspunkten zu

GlobeNewswire Inc.

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

MarketWatch

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

MarketWatch

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

MarketWatch

BioNTech SE ADR rises Monday, outperforms market - MarketWatch

MarketWatch

BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know - Yahoo Lifestyle UK

Yahoo Lifestyle UK

BioNTech SE ADR falls Friday, underperforms market - MarketWatch

MarketWatch

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

MarketWatch

Do Options Traders Know Something About BioNTech (BNTX) Stock We Don't? - Yahoo Movies UK

Yahoo Movies UK

BioNTech SE ADR falls Wednesday, underperforms market - MarketWatch

MarketWatch

BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards? - Yahoo News UK

Yahoo News UK

Are Options Traders Betting on a Big Move in BioNTech (BNTX) Stock? - Yahoo Movies UK

Yahoo Movies UK

BioNTech shares hold rating, price target raised - Investing.com India

Investing.com India

Cracking The Code: Understanding Analyst Reviews For BioNTech

Benzinga

BMO Capital cuts BioNTech stock target, keeps Outperform - Investing.com India

Investing.com India

Should Value Investors Buy BioNTech (BNTX) Stock? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

BioNTech SE ADR falls Tuesday, underperforms market - MarketWatch

MarketWatch

BioNTech SE ADR rises Monday, still underperforms market - MarketWatch

MarketWatch

BioNTech Earnings: Maintaining Our $143 Fair Value Estimate as Oncology Pipeline Remains Promising - Morningstar

Morningstar

BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript

The Motley Fool

BioNTech SE Faces Q1 Loss, Advances Oncology Trials - TipRanks.com - TipRanks

TipRanks

BioNTech SE Reports Q1 Financial Shifts - TipRanks.com - TipRanks

TipRanks

BioNTech shares dip 2% on earnings and revenue miss - Investing.com India

Investing.com India

Wall Street Looks To Extend Rally Amid Caution Over Fed Speeches, More Earnings: Why This Analyst Thinks Bull Market Is Still 'Quite Young'

Benzinga

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update - 06.05.2024 - wallstreet:online

wallstreet:online

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update - 06.05.2024 - wallstreet:online

wallstreet:online

Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More - Yahoo News UK

Yahoo News UK

BioNTech SE ADR rises Friday, still underperforms market - MarketWatch

MarketWatch

Why Earnings Season Could Be Great for BioNTech (BNTX) - Zacks Investment Research

Zacks Investment Research

Why Earnings Season Could Be Great for BioNTech (BNTX) - MSN

MSN

Why Earnings Season Could Be Great for BioNTech (BNTX)

Zacks Investment Research

BioNTech SE ADR rises Thursday, outperforms market - MarketWatch

MarketWatch

Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised

Zacks Investment Research

BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?

Zacks Investment Research

BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store? - Zacks Investment Research

Zacks Investment Research

BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store? - Zacks Investment Research

Zacks Investment Research

Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings

Zacks Investment Research

Pfizer/BioNTech to Supply 1.8B More Doses of Comirnaty in EU - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown - Investing.com UK

Investing.com UK

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

GlobeNewswire Inc.

Assessing BioNTech: Insights From 11 Financial Analysts

Benzinga

Pfizer's Doldrums, Just A Bad Case Of COVID-19?

Seeking Alpha

Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?

Zacks Investment Research

Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales? - Zacks Investment Research

Zacks Investment Research

BioNTech Reports Promising Cancer Vaccine Data - TipRanks.com - TipRanks

TipRanks

BioNTech SE Virtual AGM Scheduled for May 2024 - TipRanks.com - TipRanks

TipRanks

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer

GlobeNewswire Inc.